Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CA9 | Q16790 | 8/20 | 0.58 |
| ▸ | CA12 | O43570 | 7/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | MMP1 | P03956 | 2/20 | 0.53 |
| ▸ | MMP2 | P08253 | 2/20 | 0.53 |
| ▸ | MMP9 | P14780 | 2/20 | 0.53 |
| ▸ | MMP8 | P22894 | 2/20 | 0.53 |
| ▸ | MMP13 | P45452 | 2/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.49 |
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30675403 | 0.86 | TSHR (0.75) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL11336480 | 0.86 | TSHR (0.75) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL9618785 | 0.85 | TSHR (0.73) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL31274662 | 0.83 | SMN1; SMN2 (0.70) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL11759546 | 0.83 | TSHR (0.71) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL4796461 | 0.83 | TSHR (0.71) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL5724579 | 0.81 | TSHR (0.68) | TSHRSMN1; SMN2CA9CA12CA1 | |
| SCHEMBL11814269 | 0.80 | TSHR (0.67) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL11818487 | 0.80 | TSHR (0.67) | TSHRSMN1; SMN2CA9CA12HSD17B10 | |
| SCHEMBL2576800 | 0.79 | SMN1; SMN2 (0.66) | TSHRSMN1; SMN2CA9CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000026037-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-05-11 | — | — | WO | claimed |
| EP-4022391-B1 | HEAT SENSITIVE RECORDING MATERIAL WITH NON-PHENOLIC COLOR DEVELOPERS | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2026-03-04 | — | — | EP | disclosed |
| EP-3758947-B1 | HEAT SENSITIVE RECORDING MATERIAL AND COLOR DEVELOPER | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2025-05-14 | — | — | EP | disclosed |
| CN-114667279-B | Thermosensitive recording material containing non-phenolic color developer | 索理思科技开曼公司 | 2025-03-25 | — | — | CN | disclosed |
| US-12151497-B2 | Heat sensitive recording material with non-phenolic color developers | SOLENIS TECHNOLOGIES, L.P. (US) | 2024-11-26 | — | — | US | disclosed |
| US-11512048-B2 | Heat sensitive recording material, and color developer | SOLENIS TECHNOLOGIES, L.P. (US) | 2022-11-29 | — | — | US | disclosed |
| CN-112601668-B | Thermosensitive recording material and color-developing agent | 索理思科技开曼公司 | 2022-07-29 | — | — | CN | disclosed |
| EP-4022391-A2 | HEAT SENSITIVE RECORDING MATERIAL WITH NON-PHENOLIC COLOR DEVELOPERS | Solenis Technologies Cayman, L.P. (KY) | 2022-07-06 | — | — | EP | disclosed |
| CN-114667279-A | Heat-sensitive recording material containing non-phenol color developer | 索理思科技开曼公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-112601668-A | Thermosensitive recording material and color-developing agent | 索理思科技开曼公司 | 2021-04-02 | — | — | CN | disclosed |
| CN-1330593-A | Heat sensitive recording material | CIBA SC HOLDING AG (CH) | 2002-01-09 | — | — | CN | disclosed |
| EP-1140515-A1 | HEAT SENSITIVE RECORDING MATERIAL | Ciba SC Holding AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| EP-1115579-A1 | MONOPHASE SOLID SOLUTIONS COMPRISING A PLURALITY OF COLOUR FORMER COMPOUNDS AND PROCESS FOR THEIR PREPARATION | Ciba SC Holding AG (CH) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000035679-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-06-22 | — | — | WO | disclosed |
| US-6071853-A | Crystalline fluoran compound | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-06-06 | — | — | US | disclosed |
| WO-2000026037-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000012318-A1 | MONOPHASE SOLID SOLUTIONS COMPRISING A PLURALITY OF COLOUR FORMER COMPOUNDS AND PROCESS FOR THEIR PREPARATION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-03-09 | — | — | WO | disclosed |
| EP-0928794-A1 | Crystalline flouran compounds and their use in recording materials | Ciba SC Holding AG (CH) | 1999-07-14 | — | — | EP | disclosed |
| US-3954994-A | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents | PFIZER INC. (US) | 1976-05-04 | — | — | US | disclosed |
| US-3954994-A | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents | PFIZER INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512048-B2 | Heat sensitive recording material, and color developer | SCN1A, NCS1, SCN5A | TSHR 4630/4885SMN1; SMN2 574/4885CA9 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.